There is uncertainty whether current strategies for providing CVD risk scores  affect CVD events .
Providing CVD risk scores may slightly reduce CVD risk factor levels and may increase preventive medication prescribing in higher-risk people without evidence of harm .
BACKGROUND The current paradigm for cardiovascular disease ( CVD ) emphasises absolute risk assessment to guide treatment decisions in primary prevention .
Although the derivation and validation of multivariable risk assessment tools , or CVD risk scores , have attracted considerable attention , their effect on clinical outcomes is uncertain .
OBJECTIVES To assess the effects of evaluating and providing CVD risk scores in adults without prevalent CVD on cardiovascular outcomes , risk factor levels , preventive medication prescribing , and health behaviours .
Three-year follow-up of a factorial randomised controlled trial of two decision aids for newly diagnosed hypertensive patients.
This study is a 3-year follow-up of a factorial r and omised controlled trial of two decision aids - decision analysis and information video plus leaflet - for newly diagnosed hypertensive patients . We found no evidence of differences for either of the two decision aids compared with controls for the primary outcome of blood pressure control at follow-up . There were also no differences in any of the secondary outcomes measured - the proportion taking blood pressure lowering drugs , self-reported medication adherence , or consulting behaviour . The r and omised controlled trial cohort as a whole , irrespective of r and omised group , demonstrated substantial reductions in blood pressure and 10-year cardiovascular risk over the follow-up period
There is uncertainty whether current strategies for providing CVD risk scores  affect CVD events .
Providing CVD risk scores may slightly reduce CVD risk factor levels and may increase preventive medication prescribing in higher-risk people without evidence of harm .
BACKGROUND The current paradigm for cardiovascular disease ( CVD ) emphasises absolute risk assessment to guide treatment decisions in primary prevention .
Although the derivation and validation of multivariable risk assessment tools , or CVD risk scores , have attracted considerable attention , their effect on clinical outcomes is uncertain .
OBJECTIVES To assess the effects of evaluating and providing CVD risk scores in adults without prevalent CVD on cardiovascular outcomes , risk factor levels , preventive medication prescribing , and health behaviours .